SMBC Nikko Securities Starts Arrowhead Pharma (ARWR) at Outperform
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $86.64 +1.23%
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
SMBC Nikko Securities analyst David Hoang initiates coverage on Arrowhead Pharma (NASDAQ: ARWR) with a Outperform rating and a price target of $80.00.
For an analyst ratings summary and ratings history on Arrowhead Pharma click here. For more ratings news on Arrowhead Pharma click here.
Shares of Arrowhead Pharma closed at $33.58 yesterday.
You May Also Be Interested In
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- JPMorgan Resumes SanDisk (SNDK) at Overweight
- Axis Capital Limited Assumes Jubilant Foodworks Ltd (JUBI:IN) at Reduce (3)
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
